Compare Rush Street Interactive Inc (RSI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Rush Street Interactive Inc trades at $33.46 (market cap $3.55B), while State Street SPDR S&P Biotech ETF trades at $154.32. Which is the better fit depends on your goals.
| RSI | XBI | |
|---|---|---|
Market Cap | $3.55B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $34.52 | $164.28 |
52-Week Low | $14.55 | $85.16 |
Enterprise Value | $3.23B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $34.52, up 6.22% in 24 hours, with strong bullish momentum from technical indicators and recent earnings beats. The stock shows robust revenue growth, reaching $1.13B in 2025, and maintains a 76.92% buy rating from analysts. Positive sentiment is fueled by expansion news, such as the BetRivers launch in Alberta (GlobeNewsWire, 2026-07-13).
Outlook remains positive with earnings growth as a key catalyst, though high valuation multiples (P/E 101.53) and overbought RSI levels pose risks. The consensus price target of $31.11 suggests potential downside, but institutional bullishness and operational cash flow strength support long-term upside if execution continues.
XBI trades at $150.94, down 2.14% today, with technical indicators showing a bearish trend but oversold RSI suggesting potential near-term support. The ETF lacks traditional valuation metrics due to its structure, but recent news highlights strong biotech sector momentum, including a 17% monthly gain and robust M&A activity. Analyst coverage is limited to a single hold rating, reflecting cautious optimism amid sector volatility.
Outlook: Biotech sector tailwinds from M&A and AI-driven drug discovery offer upside, but high volatility and policy risks persist. Investors should weigh XBI's equal-weight exposure to small/mid-cap biotech against its elevated beta, with technical support near $149 critical for short-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
